Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Glioblastoma

Showing   of 10 results

Tyler Miller, MD standing in front of computer screen with another person sitting in chair looking at image of CAR T scan.

UH Seidman Researcher Parlaying Findings in Nature into More Effective Immunotherapy for Brain Tumors, Targeting Myeloid Cells

Innovations in Cancer

Christopher Hubert, PhD

Tiny Lab-Generated Microtumors Could Revolutionize Brain Cancer Treatment

UH Clinical Update | October 2024

Tiffany Hodges, MD

Physician Highlight: Tiffany Hodges, MD

Mentoring the next generation – Innovations in Neurology & Neurosurgery | Summer 2021

Helix spiral

Novel Gene Therapy Treatment for Glioblastoma Moves Forward at UH Seidman Cancer Center

Phase II clinical trial of promising approach soon to begin at UH Seidman and second site at the NIH Clinical Center - Innovations in Cancer | Winter 2021

Can the Polio Virus Kill Brain Tumors?

UH one of 4 sites participating in Phase II clinical trial - Innovations in Neurology & Neurosurgery | Winter 2020

Physician Spotlight: Andrew E. Sloan, MD

Neurosurgeon advances brain cancer research, surgical techniques - Innovations in Neurology & Neurosurgery | Winter 2020

UH Neurosurgeon Testing Novel Gene Therapy Treatment for Glioblastoma

New $2.7 million grant from the National Cancer Institute will help validate promising approach - Innovations in Cancer | Summer 2019

Newly FDA-approved Imaging Agent That Makes Brain Tumors Glow Hot Pink

Distinguishes tumor from healthy tissue to improve tumor removal The imaging agent 5-Aminolevulinic Acid (5-ALA), which helps neurosurgeons see the edges of a tumor more clearly to improve removal, was used in brain cancer surgery at University...

Results are loading...